Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 Οκτώβριος 2023NewsHumanCOVID-19Vaccines EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 Οκτώβριος 2023NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 Οκτώβριος 2023NewsHumanPharmacovigilanceReferrals EMA takes further steps to address critical shortages of medicines in the EU 24 Οκτώβριος 2023NewsHumanMedicine shortages EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens 18 Οκτώβριος 2023NewsHumanMedicines New treatment option for heavily pre-treated multiple myeloma patients 13 Οκτώβριος 2023NewsHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023 13 Οκτώβριος 2023NewsHumanMedicinesReferrals Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023 12 Οκτώβριος 2023NewsVeterinaryMedicines Monitoring of products originating from Japan for the possibility of radioactivity 11 Οκτώβριος 2023News Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 2023 6 Οκτώβριος 2023NewsVeterinaryMedicines 1 … 26 27 28 29 30 Page 30 of 384 31 32 33 34 … 384
EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 Οκτώβριος 2023NewsHumanCOVID-19Vaccines
EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 Οκτώβριος 2023NewsCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 Οκτώβριος 2023NewsHumanPharmacovigilanceReferrals
EMA takes further steps to address critical shortages of medicines in the EU 24 Οκτώβριος 2023NewsHumanMedicine shortages
EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens 18 Οκτώβριος 2023NewsHumanMedicines
New treatment option for heavily pre-treated multiple myeloma patients 13 Οκτώβριος 2023NewsHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023 13 Οκτώβριος 2023NewsHumanMedicinesReferrals
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023 12 Οκτώβριος 2023NewsVeterinaryMedicines
Monitoring of products originating from Japan for the possibility of radioactivity 11 Οκτώβριος 2023News
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 2023 6 Οκτώβριος 2023NewsVeterinaryMedicines